Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$214M |
| 2 |
Verizon
VZ
|
+$148M |
| 3 |
Otis Worldwide
OTIS
|
+$142M |
| 4 |
Baidu
BIDU
|
+$124M |
| 5 |
Alibaba
BABA
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$324M |
| 2 |
Amazon
AMZN
|
+$313M |
| 3 |
Bank of America
BAC
|
+$264M |
| 4 |
AGN
Allergan plc
AGN
|
+$259M |
| 5 |
Wells Fargo
WFC
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.39% |
| 2 | Financials | 16.29% |
| 3 | Industrials | 12.76% |
| 4 | Healthcare | 11.61% |
| 5 | Consumer Discretionary | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
OR Royalties Inc
OR
$5.52B
| $953K | ﹤0.01% |
95,274
+3,100
| +3% | +$28.6K |
|
2952
Atlantic American Corp
AAME
$32.6M
| $952K | ﹤0.01% |
580,204
-3,707
| -0.6% | -$6.95K |
|
2953
Coca-Cola Europacific Partners
CCEP
$49.2B
| $949K | ﹤0.01% |
25,165
+1,173
| +5% | +$46K |
|
|
EIGR
2954
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $941K | ﹤0.01% |
3,266
+723
| +28% | +$213K |
|
2955
Amneal Pharmaceuticals
AMRX
$5.99B
| $940K | ﹤0.01% |
197,462
+186,590
| +1,716% | +$768K |
|
2956
Veritone
VERI
$96.7M
| $938K | ﹤0.01% |
63,138
-2,990
| -5% | -$25.1K |
|
2957
LGL Group
LGL
$44.8M
| $934K | ﹤0.01% |
291,505
| – | – |
|
|
CLPR
2958
Clipper Realty
CLPR
$46.5M
| $928K | ﹤0.01% |
114,610
+10,080
| +10% | +$63.3K |
|
2959
Lantronix
LTRX
$238M
| $924K | ﹤0.01% |
248,948
-9,461
| -4% | -$29.5K |
|
|
AENZ
2960
DELISTED
Aenza S.A.A.
AENZ
| $924K | ﹤0.01% |
140,455
-3,597
| -2% | -$20.9K |
|
2961
ORIX
IX
$42.8B
| $923K | ﹤0.01% |
74,915
-45,305
| -38% | -$557K |
|
2962
Clear Channel Outdoor Holdings
CCO
$1.23B
| $921K | ﹤0.01% |
885,355
-293,876
| -25% | -$276K |
|
|
TBIO
2963
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $921K | ﹤0.01% |
51,404
-2,115
| -4% | -$31.9K |
|
2964
RCM Technologies
RCMT
$205M
| $920K | ﹤0.01% |
686,389
-116,915
| -15% | -$166K |
|
2965
Flanigan's Enterprises
BDL
$73.2M
| $917K | ﹤0.01% |
62,199
-286
| -0.5% | -$4.25K |
|
2966
Pro-Dex
PDEX
$180M
| $916K | ﹤0.01% |
51,429
+1,328
| +3% | +$23.6K |
|
|
MIXT
2967
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $914K | ﹤0.01% |
106,021
| – | – |
|
2968
CrowdStrike
CRWD
$185B
| $910K | ﹤0.01% |
36,312
-612
| -2% | -$12.3K |
|
|
MFGP
2969
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $906K | ﹤0.01% |
165,393
-222,654
| -57% | -$1.22M |
|
2970
Red Violet
RDVT
$938M
| $900K | ﹤0.01% |
51,028
| – | – |
|
|
ZYXI
2971
DELISTED
Zynex
ZYXI
| $894K | ﹤0.01% |
39,549
+2,737
| +7% | +$45.8K |
|
2972
Hudbay
HBM
$9.67B
| $887K | ﹤0.01% |
292,661
+19,319
| +7% | +$48.4K |
|
2973
Plumas Bancorp
PLBC
$433M
| $885K | ﹤0.01% |
40,001
| – | – |
|
2974
Princeton Bancorp
BPRN
$285M
| $884K | ﹤0.01% |
44,011
+1,201
| +3% | +$24.2K |
|
2975
Aldeyra Therapeutics
ALDX
$95.3M
| $874K | ﹤0.01% |
209,577
+14,650
| +8% | +$53.5K |
|
Similar funds
Dimensional Fund Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Dimensional Fund Advisors held 3,428 positions worth $228B, up 19% from $192B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Trading was light in Q2 2020: portfolio turnover was 4.2%. Dimensional Fund Advisors opened 54 new positions and exited 89, leaving the 3,428-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2020 buy was Otis Worldwide: 2,746,401 shares worth $156M.
- Dimensional Fund Advisors added most to AbbVie in Q2 2020, an estimated $214M increase.
- Dimensional Fund Advisors's biggest Q2 2020 reduction was Apple, cutting an estimated $324M.
- Dimensional Fund Advisors fully exited Allergan plc in Q2 2020, selling an estimated $259M.
- Dimensional Fund Advisors's ten largest holdings make up 12% of its $228B portfolio in Q2 2020.
- Dimensional Fund Advisors opened 54 new positions and closed 89 in Q2 2020.
- Dimensional Fund Advisors's portfolio value rose 19% quarter-over-quarter to $228B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.